D. E. Shaw & Co., Inc. Laboratory Corp Of America Holdings Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 53,238 shares of LH stock, worth $10.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

53,238

Previous 33,637 58.27%

Holding current value

$10.9 Million

Previous $7.65 Million 52.13%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$209.01 - $232.56 $4.1 Million - $4.56 Million	19,601 Added 58.27%	53,238 $11.6 Million
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $6.65 Million - $7.65 Million	33,637 New	33,637 $7.65 Million
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $2.5 Million - $2.85 Million	11,818 Added 38.99%	42,132 $10.2 Million
Q1 2023 May 15, 2023	SELL	$213.32 - $257.83 $18.8 Million - $22.7 Million	-87,948 Reduced 74.37%	30,314 $6.95 Million
Q4 2022 Feb 14, 2023	SELL	$203.72 - $248.97 $89.4 Million - $109 Million	-438,601 Reduced 78.76%	118,262 $27.8 Million

Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $27.2 Million - $34.8 Million	-132,861 Reduced 19.26%	556,863 $114 Million
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $14.2 Million - $18.5 Million	-66,475 Reduced 8.79%	689,724 $162 Million
Q1 2022 May 16, 2022	BUY	$259.82 - $298.18 $118 Million - $136 Million	454,961 Added 151.03%	756,199 $199 Million
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $38.6 Million - $44.6 Million	142,042 Added 89.22%	301,238 $94.7 Million
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $9.1 Million - $10.2 Million	-33,104 Reduced 17.21%	159,196 $44.8 Million
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $31.5 Million - $34.8 Million	124,942 Added 185.49%	192,300 $53 Million
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $54.7 Million - $68.1 Million	-266,950 Reduced 79.85%	67,358 $17.2 Million
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $11.8 Million - $13.6 Million	63,349 Added 23.38%	334,308 $68 Million
Q3 2020 Nov 16, 2020	BUY	$167.03 - $201.3 $44.5 Million - $53.6 Million	266,440 Added 5895.99%	270,959 $51 Million
Q2 2020 Aug 14, 2020	SELL	$113.31 - $182.44 $2.51 Million - $4.04 Million	-22,136 Reduced 83.05%	4,519 $751,000
Q1 2020 May 15, 2020	SELL	$104.32 - $195.28 $9.82 Million - $18.4 Million	-94,121 Reduced 77.93%	26,655 $3.37 Million
Q4 2019 Feb 14, 2020	BUY	$163.48 - $173.61 $17.6 Million - $18.6 Million	107,353 Added 799.77%	120,776 $20.4 Million
Q3 2019 Nov 14, 2019	BUY	$159.77 - $178.1 $1.7 Million - $1.9 Million	10,648 Added 383.71%	13,423 $2.26 Million
Q2 2019 Aug 14, 2019	SELL	$144.16 - $172.9 $9.42 Million - $11.3 Million	-65,353 Reduced 95.93%	2,775 $480,000
Q1 2019 May 15, 2019	BUY	$123.7 - $156.3 $4.86 Million - $6.14 Million	39,302 Added 136.34%	68,128 $10.4 Million
Q4 2018 Feb 14, 2019	BUY	$120.82 - $174.09 $991,811 - $1.43 Million	8,209 Added 39.82%	28,826 $3.64 Million
Q3 2018 Nov 14, 2018	SELL	$167.67 - $188.27 $4.64 Million - $5.21 Million	-27,696 Reduced 57.33%	20,617 $3.58 Million
Q2 2018 Aug 14, 2018	SELL	$160.33 - $189.41 $39 Million - $46.1 Million	-243,560 Reduced 83.45%	48,313 $8.67 Million
Q1 2018 May 15, 2018	SELL	$161.53 - $178.11 $8.14 Million - $8.97 Million	-50,377 Reduced 14.72%	291,873 $47.2 Million
Q4 2017 Feb 14, 2018	BUY	$147.99 - $163.95 $21.9 Million - $24.3 Million	148,095 Added 76.28%	342,250 $54.6 Million
Q3 2017 Nov 14, 2017	BUY	$149.47 - $160.56 $29 Million - $31.2 Million	194,155	194,155 $29.3 Million

Others Institutions Holding LH

# of Institutions

998

Shares Held

76.8M

Call Options Held

265K

Put Options Held

192K

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $18.3B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account